Education
About Us
Working with TipRanks
Follow Us
Onco-Innovations Ltd. (TSE:ONCO)
NEO-L:ONCO
Total Valuation
Onco-Innovations Ltd. has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
Onco-Innovations Ltd. has 54,280,552 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding54,280,552
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Onco-Innovations Ltd.’s return on equity (ROE) is -1.16 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-1.16
Return on Assets (ROA)-0.76
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee-64.37K
Employee Count1
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Onco-Innovations Ltd. is ―. Onco-Innovations Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Onco-Innovations Ltd. had revenue of 0.00 and earned -420.65K in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income-420.65K
Net Income-420.65K
EBITDA-265.63K
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.68M and capital expenditures 0.00, giving a free cash flow of -2.68M billion.
Operating Cash Flow-2.68M
Free Cash Flow-2.68M
Free Cash Flow per Share-0.05
Dividends & Yields
Onco-Innovations Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.29
52-Week Price Change145.00%
50-Day Moving Average1.47
200-Day Moving Average1.64
Relative Strength Index (RSI)45.39
Average Volume (3m)47.16K
Important Dates
Onco-Innovations Ltd. upcoming earnings date is Jul 30, 2025, During Market Hours (Not Confirmed).
Last Earnings DateApr 1, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend Date―
Financial Position
Onco-Innovations Ltd. as a current ratio of 2.62, with Debt / Equity ratio of 0.00%
Current Ratio2.62
Quick Ratio2.62
Debt to Market Cap0.00
Net Debt to EBITDA1.88
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Onco-Innovations Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Onco-Innovations Ltd. EV to EBITDA ratio is 1.88, with an EV/FCF ratio of 79.36.
EV to Sales0.00
EV to EBITDA1.88
EV to Free Cash Flow79.36
EV to Operating Cash Flow79.36
Balance Sheet
Onco-Innovations Ltd. has C$1.41M in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$1.41M billion.
Cash & Marketable SecuritiesC$1.41M
Total DebtC$0.00
Net CashC$1.41M
Net Cash Per ShareC$0.03
Tangible Book Value Per ShareC$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Onco-Innovations Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―